Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000756232 | SCV000883978 | uncertain significance | not provided | 2017-11-06 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV002222351 | SCV002500601 | uncertain significance | not specified | 2024-05-15 | criteria provided, single submitter | clinical testing | Variant summary: HBB c.271G>A (p.Glu91Lys) results in a conservative amino acid change located in the Globin of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant was absent in 251422 control chromosomes. The available data on variant occurrences in the general population are insufficient to allow any conclusion about variant significance. 271G>A has been reported in the literature in individuals without clear phenotype related to Hemoglobinopathy (examples: Paleari_1994, Panyasai_2016, Nadkarni_2018 , Yamane_2019, Luo_2004). These reports do not provide unequivocal conclusions about association of the variant with Hemoglobinopathy. The following publications have been ascertained in the context of this evaluation (PMID: 15543018, 7852091, 9785927, 31139532, 26864977, 30489691). ClinVar contains an entry for this variant (Variation ID: 15091). Based on the evidence outlined above, the variant was classified as uncertain significance. |
OMIM | RCV000016244 | SCV000036512 | other | HEMOGLOBIN AGENOGI | 2017-12-12 | no assertion criteria provided | literature only | |
Natera, |
RCV001835627 | SCV002089203 | uncertain significance | beta Thalassemia | 2020-08-11 | no assertion criteria provided | clinical testing |